SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-19-000751
Filing Date
2019-05-15
Accepted
2019-05-15 16:43:22
Documents
45
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q angiosoma20190331_10q.htm 10-Q 744211
2 EXHIBIT 31.1 ex_141345.htm EX-31.1 8655
3 EXHIBIT 32.1 ex_141346.htm EX-32.1 5616
10 angiosoma20190331_10qimg001.jpg GRAPHIC 6929
  Complete submission text file 0001185185-19-000751.txt   2725800

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT soan-20190331.xml EX-101.INS 363716
5 XBRL TAXONOMY EXTENSION SCHEMA soan-20190331.xsd EX-101.SCH 28947
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE soan-20190331_cal.xml EX-101.CAL 21662
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE soan-20190331_def.xml EX-101.DEF 157023
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE soan-20190331_lab.xml EX-101.LAB 185719
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE soan-20190331_pre.xml EX-101.PRE 159360
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 19829061
SIC: 2834 Pharmaceutical Preparations